?(en)

---

Group's publications

Neoadjuvant chemotherapy in patients with stage IV colorectal cancer: a comparison of histological response in liver metastases, primary tumors, and regional lymph nodes.
ANNALS OF SURGICAL ONCOLOGY : THE OFFICIAL JOURNAL OF THE SOCIETY OF SURGICAL ONCOLOGY
2010 vol. 17(10) pp. 2714-2719
GERVAZ P, RUBBIA-BRANDT L, ANDRES A, MAJNO P, ROTH A, MOREL P, MENTHA G

Continuous Sunitinib treatment in patients with advanced hepatocellular carcinoma: a Swiss Group for Clinical Cancer Research (SAKK) and Swiss Association for the Study of the Liver (SASL) multicenter phase II trial (SAKK 77/06).
THE ONCOLOGIST
2010 vol. 15(3) pp. 285-292
KOEBERLE D AND AL.

Surgical outcome after docetaxel-based neoadjuvant chemotherapy in locally-advanced gastric cancer.
WORLD JOURNAL OF GASTROENTEROLOGY
2010 vol. 16(7) pp. 868-874
BIFFI R AND AL.

Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02).
ANNALS OF ONCOLOGY
2009 vol. 20(9) pp. 1522-1528
RUHSTALLER T AND AL.

Dangerous halo after neoadjuvant chemotherapy and two-step hepatectomy for colorectal liver metastases.
BRITISH JOURNAL OF SURGERY
2009 vol. 96(1) pp. 95-103
MENTHA G, TERRAZ S, MOREL P, ANDRES A, GIOSTRA E, ROTH A, RUBBIA-BRANDT L, MAJNO P

Tissue Biomarker Development in a Multicentre Trial Context: a Feasibility Study on the PETACC3 Stage II and III Colon Cancer Adjuvant Treatment Trial
CLINICAL CANCER RESEARCH
2009 vol. 15 pp. 5528-5533
BOSMAN FT, YAN P, TEJPAR S, FIOCCA R, VAN CUTSEM A, KENNEDY RD, DIETRICH D, ROTH A

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib.
EUROPEAN JOURNAL OF CANCER
2009 vol. 45(13) pp. 2293-2297
MONTEMURRO M AND AL.

Randomized Phase III Trial Comparing Biweekly Infusional Fluorouracil/Leucovorin Alone or With Irinotecan in the Adjuvant Treatment of Stage III Colon Cancer: PETACC-3
JOURNAL OF CLINICAL ONCOLOGY
2009 vol. 27(19) pp. 3117-3125
VAN CUTSEM E AND AL.

Is a change in patient-reported dysphagia after induction chemotherapy in locally advanced esophageal cancer a predictive factor for pathological response to neoadjuvant chemoradiation?
SUPPORTIVE CARE IN CANCER
2009 vol. 17 pp. 1109-1116
RIBI K AND AL.

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial.
THE LANCET ONCOLOGY
2009 vol. 10(8) pp. 785-793
STUPP R AND AL.

Adding cetuximab to capecitabine plus oxaliplatin (XELOX) in first-line treatment of metastatic colorectal cancer: a randomized phase II trial of the Swiss Group for Clinical Cancer Research SAKK.
ANNALS OF ONCOLOGY
2008 vol. 19(7) pp. 1288-1292
BORNER M AND AL.

Improved long-term outcome of surgery for advanced colorectal liver metastases: reasons and implications for management on the basis of a severity score.
ANNALS OF SURGICAL ONCOLOGY : THE OFFICIAL JOURNAL OF THE SOCIETY OF SURGICAL ONCOLOGY
2008 vol. 15(1) pp. 134-143
ANDRES A, MAJNO PE, MOREL P, RUBBIA-BRANDT L, GIOSTRA E, GERVAZ P, TERRAZ S, ALLAL AS, ROTH AD, MENTHA G

'Liver first' approach in the treatment of colorectal cancer with synchronous liver metastases.
DIGESTIVE SURGERY
2008 vol. 25(6) pp. 430-435
MENTHA G, ROTH AD, TERRAZ S, GIOSTRA E, GERVAZ P, ANDRES A, MOREL P, RUBBIA-BRANDT L, MAJNO PE

European Organisation of Research and Treatment of Cancer (EORTC) Gastrointestinal Group: Workshop on the role of metabolic imaging in the neoadjuvant treatment of gastrointestinal cancer.
EUROPEAN JOURNAL OF CANCER
2008 vol. 44(13) pp. 1807-1819
LORDICK F AND AL.

Expert opinion on management of gastric and gastro-oesophageal junction adenocarcinoma on behalf of the European Organisation for Research and Treatment of Cancer (EORTC)-gastrointestinal cancer group .
EUROPEAN JOURNAL OF CANCER
2008 vol. 44(2) pp. 182-194
VAN CUTSEM E, VAN DE VELDE C, ROTH AD, LORDICK F, KÖHNE CH, CASCINU S, AAPRO M

Importance of histological tumor response assessment in predicting the outcome in patients with colorectal liver metastases treated with neo-adjuvant chemotherapy followed by liver surgery
ANNALS OF ONCOLOGY
2007 vol. 18 pp. 299-304
RUBBIA-BRANDT, L, GIOSTRA, E, BREZAULT, C, ROTH, AD, ANDRES, A, AUDARD, V, SARTORETTI, P, DOUSSET, B, MAJNO, PE, SOUBRANE, O, CHAUSSADE, S, MENTHA, G, TERRIS, B

Multicenter trial of neo-adjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma
ANNALS OF ONCOLOGY
2007 vol. 18 pp. 1196-1202
WEDER, W, STAHEL, RA, BERNHARD, J, BODIS, S, VOGT, P, BALLABENI, P, LARDINOIS, D, BETTICHER, D, SCHMID, R, STUPP, R, RIS, HB, JERMANN, M, MINGRONE, W, ROTH, AD, SPILIOPOULOS, A

The management of pancreatic cancer. Current expert opinion and recommendations derived from the 8th World Congress on Gastrointestinal Cancer, Barcelona, 2006
ANNALS OF ONCOLOGY
2007 vol. 18 pp. 1-10
VERSLYPE C, VAN CUTSEM E, DICATO M, CASCINU S, CUNNINGHAM D, DIAZ-RUBIO E, GLIMELIUS B, HALLER D, HAUSTERMANS K, HEINEMANN V, HOFF P, JOHNSTON PG, KERR D, LABIANCA R, LOUVET C, MINSKY B, MOORE M, NORDLINGER B, PEDRAZZOLI S, ROTH A, ROTHENBERG M

Response from authors: Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
BRITISH JOURNAL OF SURGERY
2007 vol. 94 pp. 386-386
MENTHA G, MAJNO PE, ALLAL AS, ROTH AD

Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour
EJSO
2007 vol. 33 Suppl 2 pp. 76-83
MENTHA G, MAJNO P, MOREL PH, TERRAZ S, RUBBIA-BRANDT L, GERVAZ P, ANDRES A, ALLAL AS, ROTH AD

A randomised phase II study of OSI-7904L versus 5-fluorouracil (FU)/leucovorin (LV) as first-line treatment in patients with advanced biliary cancers.
INVESTIGATIONAL NEW DRUGS
2007 vol. 25(4) pp. 385-390
CIULEANU T., DICULESCU M., HOEPFFNER N.M., TROJAN J., SAILER V., ZALUPSKI M., HERRMANN T., ROTH A., CHICK J., BROCK K., ALBERT D., PHILIP P.A.

Docetaxel, cisplatin, and fluorouracil; Docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: A randomized phase II trial of the Sw iss Group for Clinical Cancer Research
JOURNAL OF CLINICAL ONCOLOGY
2007 vol. 25 pp. 3217-3223
ROTH, AD, FAZIO, N, STUPP, R, FALK, S, BERNHARD, J, SALETTI, P, KOBERLE, D, BORNER, MM, RUFIBACH, K, MAIBACH, R, WERNLI, M, LESLIE, M, GLYNNE-JONES, R, WIDMER, L, SEYMOUR, M, DE BRAUD, F

Re: Adjuvant treatment of high-risk, radically resected gastric cancer patients with 5-fluorouracil, leucovorin, cisplatin, and epidoxorubicin in a Randomized Controlled Trial
JOURNAL OF THE NATIONAL CANCER INSTITUTE
2007 vol. 99 pp. 1345-1346
FAZIO N, BIFFI R, CURIGLIANO G, LORRIZO K, ZAMPINO MG, DE BRAUD F, CHIAPPA A, ROTH AD, GOLDHIRSCH A

The neo-adjuvant, surgical and adjuvant treatment of gastric adenocarcinoma. current expert opinion derived from the Seventh World Congress on Gastrointestinal Cancer, Barcelona, 2005
ANNALS OF ONCOLOGY
2006 vol. 17 pp. 13-18
VAN CUTSEM E, DICATO M, ARBER N, BENSON A, CUNNINGHAM D, DIAZ-RUBIO E, GLIMELIUS B, GOLDBERG R, HALLER D, HAUSTERMANS K, KOO-KANG Y, LABIANCA R, LANG I, MINSKY B, NORDLINGER B, ROTH A, ROUGIER P

Prognostic factors affecting long-term outcomes in patients with resected stage IIIA pN2 non-small-cell lung cancer: 5-year follow-up of a phase II study
BRITISH JOURNAL OF CANCER
2006 vol. 4(8) pp. 1099-1106
BETTICHER DC ET AL.

Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary
BRITISH JOURNAL OF SURGERY
2006 vol. 93 pp. 872-878
MENTHA G, MAJNO PE, ANDRES A, RUBBIA-BRANDT L, MOREL P, ROTH AD

Complete closure of cancer-related anovaginal and anoperineal fistulas in locally advanced anal canal carcinomas by upfront intra-arterial chemotherapy followed by combined radiochemotherapy: report o f two cases
DISEASES OF THE COLON & RECTUM
2006 vol. 49(12) pp. 1927-1930
ROSSET L, ALLAL AS, MOREL P, ROCHE B, ROTH AD

Docetaxel-based chemotherapy in the treatment of gastric cancer
ANNALS OF ONCOLOGY
2003 vol. 14 pp. 41-44
ROTH AD, AJANI J

---

Research's domains